Genprex (GNPX) Change in Accured Expenses (2016 - 2025)

Genprex (GNPX) has 10 years of Change in Accured Expenses data on record, last reported at -$573256.0 in Q3 2025.

  • For Q3 2025, Change in Accured Expenses fell 543.28% year-over-year to -$573256.0; the TTM value through Sep 2025 reached -$830850.0, up 38.02%, while the annual FY2024 figure was -$426723.0, 16.45% up from the prior year.
  • Change in Accured Expenses reached -$573256.0 in Q3 2025 per GNPX's latest filing, down from $889369.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $2.0 million in Q4 2022 and bottomed at -$1.2 million in Q4 2023.
  • Average Change in Accured Expenses over 5 years is $57915.0, with a median of $129322.0 recorded in 2024.
  • Peak YoY movement for Change in Accured Expenses: tumbled 947.84% in 2022, then skyrocketed 4158.82% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at $468030.0 in 2021, then soared by 336.85% to $2.0 million in 2022, then crashed by 160.99% to -$1.2 million in 2023, then skyrocketed by 73.28% to -$333235.0 in 2024, then tumbled by 72.03% to -$573256.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were -$573256.0 in Q3 2025, $889369.0 in Q2 2025, and -$813728.0 in Q1 2025.